Shaokun Shu

6PUBLICATIONS
70CO-AUTHORS
Molecular targetsNanometrologyFormal methods for softwareCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 16, 2026
Genome-wide screenings identify BAP1 as a synthetic-lethality target with CDK4/6 inhibitors.

Mei Feng, Hong Liu, Lu Zheng

|Jul 14, 2025
Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury.

Zhiqiang Zhao, Xinzhu Shan, Jing Ding

|Jan 20, 2025
UDA-seq: universal droplet microfluidics-based combinatorial indexing for massive-scale multimodal single-cell sequencing.

Yun Li, Zheng Huang, Lubin Xu

|Jul 18, 2024
Single-cell EpiChem jointly measures drug-chromatin binding and multimodal epigenome.

Chao Dong, Xiaoxuan Meng, Tong Zhang

|Sep 07, 2023
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer.

Maša Alečković, Zheqi Li, Ningxuan Zhou

|Nov 21, 2022
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.

Laura E Stevens, Guillermo Peluffo, Xintao Qiu

Pageof 1

Frequent Collaborators

2 joint publications

Xintao Qiu

2 joint publications

Zheqi Li

2 joint publications

Kornelia Polyak

2 joint publications

Henry W Long